RTX (NYSE:RTX) stock Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/16/2024 | 8.29% | Baird | $88 → $94 | Downgrades | Outperform → Neutral |
| 11/15/2023 | — | Redburn Atlantic | Downgrades | Buy → Neutral | |
| 10/25/2023 | -0.92% | Morgan Stanley | $83 → $86 | Maintains | Equal-Weight |
| 10/11/2023 | -7.83% | UBS | $110 → $80 | Downgrades | Buy → Neutral |
| 09/29/2023 | -6.68% | Alembic Global | → $81 | Initiates Coverage On | → Neutral |
| 09/25/2023 | -5.53% | RBC Capital | → $82 | Reiterates | Sector Perform → Sector Perform |
| 09/25/2023 | -4.38% | Morgan Stanley | $95 → $83 | Maintains | Equal-Weight |
| 09/18/2023 | -10.14% | Wells Fargo | $100 → $78 | Maintains | Equal-Weight |
| 09/14/2023 | -8.99% | DZ Bank | → $79 | Downgrades | Buy → Hold |
| 09/14/2023 | -13.59% | B of A Securities | $95 → $75 | Downgrades | Neutral → Underperform |
| 09/13/2023 | 0.23% | JP Morgan | $100 → $87 | Maintains | Overweight |
| 09/12/2023 | 14.06% | TD Cowen | $109 → $99 | Maintains | Outperform |
| 09/12/2023 | -5.53% | RBC Capital | $105 → $82 | Downgrades | Outperform → Sector Perform |
| 09/12/2023 | -13.59% | Barclays | $100 → $75 | Downgrades | Overweight → Equal-Weight |
| 07/31/2023 | — | Argus Research | Downgrades | Buy → Hold | |
| 07/27/2023 | 9.45% | Citigroup | $113.5 → $95 | Maintains | Neutral |
| 07/27/2023 | 9.45% | B of A Securities | $120 → $95 | Downgrades | Buy → Neutral |
| 07/26/2023 | 26.73% | Susquehanna | $117 → $110 | Maintains | Positive |
| 07/26/2023 | 20.97% | RBC Capital | $110 → $105 | Maintains | Outperform |
| 07/26/2023 | 15.21% | Wells Fargo | $98 → $100 | Maintains | Equal-Weight |
| 07/26/2023 | 9.45% | Morgan Stanley | $110 → $95 | Downgrades | Overweight → Equal-Weight |
| 06/26/2023 | 26.73% | Morgan Stanley | $115 → $110 | Maintains | Overweight |
| 06/20/2023 | 26.73% | RBC Capital | → $110 | Reiterates | Outperform → Outperform |
| 04/26/2023 | 30.76% | Citigroup | $106 → $113.5 | Maintains | Neutral |
| 04/26/2023 | 26.73% | RBC Capital | → $110 | Reiterates | → Outperform |
| 04/26/2023 | 34.79% | Susquehanna | $116 → $117 | Maintains | Positive |
| 04/26/2023 | 26.73% | Credit Suisse | $105 → $110 | Maintains | Neutral |
| 04/26/2023 | 32.49% | Baird | $106 → $115 | Maintains | Outperform |
| 04/20/2023 | 26.73% | Jefferies | $115 → $110 | Downgrades | Buy → Hold |
| 04/12/2023 | 34.79% | Wolfe Research | → $117 | Upgrades | Peer Perform → Outperform |
| 01/26/2023 | 22.12% | Citigroup | $104 → $106 | Maintains | Neutral |
| 01/25/2023 | 23.27% | Wells Fargo | $96 → $107 | Maintains | Equal-Weight |
| 01/25/2023 | 22.12% | Credit Suisse | $103 → $106 | Maintains | Neutral |
| 01/19/2023 | 32.49% | Morgan Stanley | $119 → $115 | Maintains | Overweight |
| 01/13/2023 | 20.97% | Goldman Sachs | $115 → $105 | Downgrades | Buy → Neutral |
| 01/12/2023 | 18.66% | Credit Suisse | $83 → $103 | Maintains | Neutral |
| 12/12/2022 | 23.27% | JP Morgan | $102 → $107 | Maintains | Overweight |
| 12/08/2022 | 19.82% | Citigroup | → $104 | Initiates Coverage On | → Neutral |
| 10/26/2022 | 22.12% | Baird | $117 → $106 | Maintains | Outperform |
| 10/26/2022 | 37.1% | Morgan Stanley | $124 → $119 | Maintains | Overweight |
| 10/26/2022 | 17.51% | RBC Capital | $107 → $102 | Maintains | Outperform |
| 10/26/2022 | 10.6% | Wells Fargo | $98 → $96 | Maintains | Equal-Weight |
| 10/26/2022 | -4.38% | Credit Suisse | $85 → $83 | Maintains | Neutral |
| 10/12/2022 | -2.07% | Credit Suisse | → $85 | Initiates Coverage On | → Neutral |
| 10/11/2022 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 07/27/2022 | 12.9% | Wells Fargo | $106 → $98 | Maintains | Equal-Weight |
| 07/27/2022 | 32.49% | RBC Capital | $125 → $115 | Maintains | Outperform |
| 04/27/2022 | 49.77% | B of A Securities | $115 → $130 | Maintains | Buy |
| 04/27/2022 | 22.12% | Wells Fargo | $96 → $106 | Maintains | Equal-Weight |
| 04/08/2022 | 44.01% | RBC Capital | → $125 | Initiates Coverage On | → Outperform |
| 03/10/2022 | 23.27% | Barclays | $100 → $107 | Maintains | Overweight |
| 03/02/2022 | 42.86% | Morgan Stanley | $118 → $124 | Maintains | Overweight |
| 01/26/2022 | 35.94% | Morgan Stanley | $110 → $118 | Maintains | Overweight |
| 01/26/2022 | 10.6% | Wells Fargo | $97 → $96 | Maintains | Equal-Weight |
| 07/29/2021 | 15.21% | Argus Research | → $100 | Upgrades | Hold → Buy |
| 07/28/2021 | 20.97% | Susquehanna | $97 → $105 | Maintains | Positive |
| 06/03/2021 | 20.97% | Jefferies | $95 → $105 | Maintains | Buy |
| 05/19/2021 | 9.45% | Credit Suisse | $94 → $95 | Maintains | Outperform |
| 05/13/2021 | 0.23% | Wells Fargo | → $87 | Initiates Coverage On | → Equal-Weight |
| 05/07/2021 | — | Redburn Partners | Initiates Coverage On | → Buy | |
| 04/28/2021 | 11.75% | Morgan Stanley | $89 → $97 | Maintains | Overweight |
| 04/14/2021 | 3.69% | Credit Suisse | $81 → $90 | Maintains | Outperform |
| 04/12/2021 | 4.84% | Susquehanna | $83 → $91 | Maintains | Positive |
| 04/09/2021 | 11.75% | Wolfe Research | → $97 | Initiates Coverage On | → Outperform |
| 12/17/2020 | -0.92% | DZ Bank | → $86 | Upgrades | Hold → Buy |
| 11/10/2020 | -8.99% | JP Morgan | → $79 | Upgrades | Neutral → Overweight |
| 10/12/2020 | -13.59% | Credit Suisse | $81 → $75 | Maintains | Outperform |
| 09/08/2020 | 2.53% | Morgan Stanley | → $89 | Initiates Coverage On | → Overweight |
| 07/29/2020 | -17.05% | JP Morgan | $70 → $72 | Maintains | Neutral |
| 07/10/2020 | -11.29% | Vertical Research | $52 → $77 | Upgrades | Hold → Buy |
| 06/25/2020 | -19.35% | Citigroup | $85.52 → $70 | Maintains | Neutral |
| 06/02/2020 | -18.2% | Cowen & Co. | $65 → $71 | Maintains | Outperform |
| 05/21/2020 | -20.51% | RBC Capital | → $69 | Initiates Coverage On | → Outperform |
| 05/11/2020 | -7.83% | Jefferies | $85 → $80 | Maintains | Buy |
| 05/08/2020 | -27.42% | RBC Capital | $61 → $63 | Maintains | Sector Perform |
| 05/07/2020 | -25.12% | CFRA | $71 → $65 | Maintains | Buy |
| 04/20/2020 | -6.68% | Credit Suisse | $101 → $81 | Maintains | Outperform |
| 04/15/2020 | -12.44% | Goldman Sachs | → $76 | Reinstates | → Buy |
| 04/09/2020 | -6.68% | UBS | $158 → $81 | Maintains | Buy |
| 04/08/2020 | -33.18% | Vertical Research | → $58 | Initiates Coverage On | → Hold |